Health Care

USPSTF upgrades PSA test recommendation for prostate cancer screening

USPSTF upgrades PSA test recommendation for prostate cancer screening

Whether to get screened for prostate cancer is a question that men aged 55 to 69 should decide themselves in consultation with their doctors, according to finalized guidance issued Tuesday by an influential panel of health care experts. Afterwards, in 2012, the USPSTF (United States Preventative Services Task Force) claimed that PSA testing did more damage than good. Clinicians should not screen men who do not express a preference for screening. However, with regard to older patients ( 70 years), the AUA stated that "select older, healthier men may garner a benefit" from PSA screening. Six years ago, the USA... An elevated PSA level may be caused by prostate cancer, but it could also be caused by other conditions, such as an enlarged prostate or inflammation of the prostate.

"We think that the important part of this recommendation, which should be stressed, is that we should let each man decide himself, based on his own perception of the risks and benefits, whether he wants to be screened", said Dr. Danny Vespini and genetic counselor Justin Lorentz, who run the Male Oncology Research & Education Program at the University of Toronto and were not involved in the USPSTF guidelines.

Whether to choose treatment if cancer is detected. Specifically, clinicians should inform their African American patients about their increased risk of developing and dying from prostate cancer, as well as the potential benefits and harms of screening.

What to expect from Google I/O 2018
Google and JBL are buddying up to create a one of a kind, hybrid soundbar that is powered by Android TV . Android P , on the other hand, appears to focus on improvements to visual elements and interface design.

That's because prostate cancer grows slowly and over-treatment can cause impotence and incontinence. Many men with prostate cancer never experience symptoms and, without screening, would never know they have the disease.

Findings from an evidence review conducted by the Task Force revealed that for men aged 55-69 years, PSA-based screening programs prevented roughly 1.3 deaths over approximately 13 years per 1000 men screened.

USPSTF, Vice Chairman, Dr. Krist, Virginia Commonwealth University, Family medicine, and Population Health, said, "The prolonged follow up of 10+ years in this research, which was not handy in 2012, had a huge contribution in the decision of making the changes in the guidelines of screening".